Bin Yang

Bin Yang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
DHDong Hou
Dong Hou
JTJia-Nan Tan
Jia-Nan Tan
SZSheng-Ning Zhou
Sheng-Ning Zhou
XYXu Yang
Xu Yang
ZZZhi-Hong Zhang
Zhi-Hong Zhang
FHFanhai Han
Fanhai Han
Background: Colorectal cancer (CRC) is a common malignant tumor that affects the large bowel or the rectum. Cuproptosis, recently discovered programmed cell death process, may play an important role in CRC tumorigenesis. Long non-coding RNAs (lncRNAs) can alter the proliferation of colorectal cancer cells through the control and activation of gene expression. To date, cuproptosis-related lncRNAs, have not been investigated as potential predictive biomarkers in colorectal cancer.Methods: The mRNA and lncRNA expression data of colorectal cancer were gathered from The Tumor Genome Atlas (TCGA) database, and Pearson correlation analysis and univariate Cox regression analysis were used to identify the lncRNAs with differential prognosis. Colorectal cancer was classified using consistent clustering, and the clinical significance of different types, tumor heterogeneity, and immune microenvironment differences was investigated. The differential lncRNAs were further screened using LASSO regression to develop a risk scoring model, which was then paired with clinicopathological variables to create a nomogram. Finally, the copy number changes in the high-risk and low-risk groups were compared.Results: Two clusters were formed based on the 28 prognostic cuproptosis-related lncRNAs, and the prognosis of cluster 2 was found to be significantly lower than that of cluster 1. Cluster 1 showed increased immune cell infiltration and immunological score, as well as strong enrichment of immune checkpoint genes. Next, LASSO regression was used to select 11 distinctive lncRNAs, and a risk score model was constructed using the training set to distinguish between high and low-risk groups. Patients in the high-risk group had a lower survival rate than those in the low-risk group, and both the test set and the total set produced consistent results. The AUC value of the ROC curve revealed the scoring model’s efficacy in predicting long-term OS in patients. Moreover, the model could be used as an independent predictor when combined with a multivariate analysis of clinicopathological features, and our nomogram could be used intuitively to predict prognosis.Conclusion: Collectively, we developed a risk model using 11 differential lncRNAs and demonstrated that the model has predictive value as well as clinical and therapeutic implications for predicting prognosis in CRC patients.

25 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
GZGuangyu Zhong
Guangyu Zhong
JTJia-Nan Tan
Jia-Nan Tan
JHJing Huang
Jing Huang
SZSheng-Ning Zhou
Sheng-Ning Zhou
JYJin-Hao Yu
Jin-Hao Yu
FHFanhai Han
Fanhai Han
Many studies reported that long noncoding RNAs (lncRNAs) play a critical role in gastric cancer (GC) metastasis and tumorigenesis. However, the underlying mechanisms of lncRNAs in GC remain unexplored to a great extent. LINC01537 expression level was detected using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC). Its biological roles in GC were then investigated using functional experiments. In order to investigate the underlying mechanism of LINC01537 in GC, RNA pull-down, RNA immunoprecipitation, and ubiquitination assays were performed. LINC01537 was significantly overexpressed in GC tissues and associated with a poor prognosis. Functional experimental results revealed that LINC01537 promoted the proliferation, invasion, and migration of GC cells. The animal experiments revealed that LINC01537 promoted tumorigenesis and metastasis in vivo. Mechanistically, LINC01537 stabilizes RIPK4 by reducing the binding of RIPK4 to TRIM25 and reducing its ubiquitination degradation, thereby promoting the expression of the NF-κB signaling pathway. According to our findings, the LINC01537-RIPK4-NF-κB axis promoted GC metastasis and tumorigenesis.

3 November 2023 in Translational Oncology
Verified
Journal Article
Open access
JYJin-Hao Yu
Jin-Hao Yu
JTJia-Nan Tan
Jia-Nan Tan
GZGuang-Yu Zhong
Guang-Yu Zhong
LZLin Zhong
Lin Zhong
DHDong Hou
Dong Hou
HFhan fanghai
han fanghai
Circular RNAs (circRNAs) are a distinct class of non-coding RNAs that play regulatory roles in the initiation and progression of tumors. With advancements in transcriptome sequencing technology, numerous circRNAs that play significant roles in tumor-related genes have been identified. In this study, we used transcriptome sequencing to analyze the expression levels of circRNAs in normal adjacent tissues, primary colorectal cancer (CRC) tissues, and CRC tissues with liver metastasis. We successfully identified the circRNA hsa_circ_0020134 (circ0020134), which exhibited significantly elevated expression specifically in CRC with liver metastasis. Importantly, high levels of circ0020134 were associated with a poor prognosis among patients. Functional experiments demonstrated that circ0020134 promotes the proliferation and metastasis of CRC cells both in vitro and in vivo. Mechanistically, upregulation of circ0020134 was induced by the transcription factor, PAX5, while miR-183-5p acted as a sponge for circ0020134, leading to partial upregulation of PFN2 mRNA and protein levels, thereby further activating the downstream TGF-β/Smad pathway. Additionally, downregulation of circ0020134 inhibited epithelial-mesenchymal transition (EMT) in CRC cells, which could be reversed by miR-183-5p inhibitor treatment. Collectively, our findings confirm that the circ0020134-miR-183-5p-PFN2-TGF-β/Smad axis induces EMT transformation within tumor cells, promoting CRC proliferation and metastasis, thus highlighting its potential as a therapeutic target for patients with CRC liver metastasis.

12 July 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
SZShilin Zhi
Shilin Zhi
BYBin Yang
Bin Yang
SZSheng-Ning Zhou
Sheng-Ning Zhou
JTJianan Tan
Jianan Tan
GZGuangyu Zhong
Guangyu Zhong
FHFanhai Han
Fanhai Han
Background: Gastric cancer is a prevalent cause of tumor death. Tumor immunotherapy aims to reshape the specific immunity to tumors in order to kill the tumor. LncRNAs play a pivotal role in regulating the tumor immune microenvironment. Herein, immune-related lncRNAs were used to establish a prognosis risk-assessment model for gastric cancer and provide personalized predictions while providing insights and targets for gastric cancer treatment to enhance patient prognosis. Methods: Gastric adenocarcinoma transcriptome and clinical data were acquired from the The Cancer Genome Atlas (TCGA) database to screen the immune-related lncRNAs. Then, LASSO COX regression was utilized to construct the prognosis risk-assessment model. Afterward, the reliability of the model was evaluated the relationship between immune infiltration, clinical characteristics, and the model was analyzed. Results: We identified 13 lncRNAs and constructed the prognosis assessment model. According to the median risk score of the training set, the patients were assigned to different risk groups. Overall survival time was shorter in the high-risk group. In the high-risk group, higher infiltration of mono-macrophages, dendritic cells, CD4+ T cells, and CD8+ T cells was observed. Moreover, the model was positively related to tumor metastasis. Conclusion: The prognosis risk-assessment model developed in this research can effectively predict the prognosis of gastric cancer patients. This tool is expected to be further applied to clinics in the future, thus providing a novel target for immunotherapy in gastric cancer patients.

22 January 2025 in Heliyon
Verified
Journal Article
Open access
LGLong Gui
Long Gui
JYJin-Hao Yu
Jin-Hao Yu
JTJia-Nan Tan
Jia-Nan Tan
GZGuang-Yu Zhong
Guang-Yu Zhong
YWYong-Xue Wang
Yong-Xue Wang
SZSheng-Ning Zhou
Sheng-Ning Zhou
Carbohydrate sulfotransferase (CHST) is a Golgi membrane-associated enzyme with potential as a cancer diagnostic marker. In this study, we obtained the transcriptional profile and corresponding clinical information of CHST1 in gastric cancer (GC) tissues and normal tissues from The Cancer Genome Atlas database. Our functional experiments have demonstrated that CHST1 enhances the proliferation and metastasis of GC cells, both in vitro and in vivo. Furthermore, we constructed a co-expression network of CHST1 and explored its relationship with clinicopathological features, the tumor microenvironment, and immune infiltration through bioinformatics analysis. Finally, relevant drugs that inhibit CHST1 in GC were predicted using the drug susceptibility database (CellMiner) and Cancer Immunome Atlas. Overall, CHST1 may serve as a promising prognostic biomarker for GC, as it is linked to immune infiltration and facilitates GC cell proliferation and metastasis.

24 September 2026 in Cancers
Verified
Journal Article
Open access
PDF file
HYHan Yang
Han Yang
JYJinhao Yu
Jinhao Yu
DHDong Hou Hou
Dong Hou Hou
JLJiaxin Lin
Jiaxin Lin
GCGuangyao Chen
Guangyao Chen
HLHong-ming Li
Hong-ming Li
Background: Colorectal cancer liver metastasis (CRLM) remains a major cause of mortality in colorectal cancer (CRC), while the upstream molecular mechanisms linking tumor cell adaptation and immune microenvironment remodeling remain poorly understood. Methods: By integrating single-cell RNA sequencing, multi-omics analysis, clinical cohorts, and functional experiments, we investigated the role and mechanism of TCF4 post-translational modification in CRLM progression. Results: We identified O-GlcNAcylated TCF4 as a critical driver of CRLM. TCF4 was significantly upregulated in CRLM and associated with poor prognosis. Mechanistically, OGT-mediated O-GlcNAcylation at Ser163 promoted TCF4 nuclear localization and enhanced its transcriptional activity. O-GlcNAcylated TCF4 directly activated GPX4 transcription, conferring ferroptosis resistance and preserving the malignant characteristics of CRC cells. Furthermore, TCF4 promoted CSF1 secretion, activating the CSF1/CSF1R axis to facilitate TAM recruitment and M2 macrophage polarization, thereby establishing an immunosuppressive metastatic niche. Conclusions: Our study reveals an O-GlcNAcylated TCF4–ferroptosis–immune regulatory axis that coordinates tumor intrinsic adaptation and microenvironmental remodeling during CRLM progression, providing potential therapeutic targets for preventing CRLM.